You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Références<br />
96. Eyster ME, Alter HJ, A<strong>le</strong>dort LM, Quan S, Hatzakis A, Goedert JJ. Heterosexual co-transmission of hepatitis<br />
C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med. 1991 Nov 15;115(10):764-8.<br />
97. Hisada M, O'Brien TR, Rosenberg PS, Goedert JJ. Virus load and risk of heterosexual transmission of human<br />
immunodeficiency virus and hepatitis C virus by men with hemophilia. The Multicenter Hemophilia Cohort<br />
Study. J Infect Dis. 2000 Apr;181(4):1475-8.<br />
98. Cooper CL, Cameron DW. Review of the effect of highly active antiretroviral therapy on hepatitis C virus<br />
(HCV) RNA <strong>le</strong>vels in human immunodeficiency virus and HCV coinfection. Clin Infect Dis. 2002 Oct<br />
1;35(7):873-9.<br />
99. Zylberberg H, Chaix ML, Rabian C, Rouzioux C, Aulong B, Brechot C, et al. Tritherapy for human<br />
immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects. Clin<br />
Infect Dis. 1998 May;26(5):1104-6.<br />
100. Rockstroh JK, Theisen A, Kaiser R, Sauerbruch T, Speng<strong>le</strong>r U. Antiretroviral trip<strong>le</strong> therapy decreases HIV<br />
viral load but does not alter hepatitis C virus (HCV) serum <strong>le</strong>vels in HIV-HCV-co-infected haemophiliacs.<br />
Aids. 1998 May 7;12(7):829-30.<br />
101. Matsiota-Bernard P, Vrioni G, Onody C, Bernard L, de Truchis P, Peronne C. Human immunodeficiency<br />
virus (HIV) protease inhibitors have no effect on hepatitis C virus (HCV) serum <strong>le</strong>vels of HIV-HCV coinfected<br />
patients. Int J Antimicrob Agents. 2001 Feb;17(2):155-7.<br />
102. Puoti M, Gargiulo F, Roldan EQ, Chiodera A, Palvarini L, Spinetti A, et al. Liver damage and kinetics of<br />
hepatitis C virus and human immunodeficiency virus replication during the early phases of combination<br />
antiretroviral treatment. J Infect Dis. 2000 Jun;181(6):2033-6.<br />
103. Sherman KE, Shire NJ, Cernohous P, Rouster SD, Omachi JH, Brun S, et al. Liver injury and changes in<br />
hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for<br />
treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir. Clin Infect Dis. 2005 Oct<br />
15;41(8):1186-95.<br />
104. Neau D, Trimou<strong>le</strong>t P, Pereira E, Lafon ME, Gervais A, Ragnaud JM, et al. Evolution of plasma hepatitis C<br />
virus load in patients coinfected by HIV and hepatitis C Virus started on a protease inhibitor-containing<br />
antiretroviral regimen, Agence Nationa<strong>le</strong> de Recherches sur <strong>le</strong> SIDA CO8 APROCO-COPILOTE cohort. J<br />
Acquir Immune Defic Syndr. 2008 Jun 1;48(2):227-9.<br />
105. Rutschmann OT, Negro F, Hirschel B, Hadengue A, Anwar D, Perrin LH. Impact of treatment with human<br />
immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J<br />
Infect Dis. 1998 Mar;177(3):783-5.<br />
106. John M, F<strong>le</strong>xman J, French MA. Hepatitis C virus-associated hepatitis following treatment of HIV-infected<br />
patients with HIV protease inhibitors: an immune restoration disease Aids. 1998 Dec 3;12(17):2289-93.<br />
107. Cribier B, Schmitt C, Rey D, Lang JM, Kirn A, Stoll-Kel<strong>le</strong>r F. Ro<strong>le</strong> of endogenous interferon in hepatitis C<br />
virus (HCV) infection and in coinfection by HIV and HCV. Res Virol. 1996 Sep-Oct;147(5):263-6.<br />
108. Dorrucci M, Pezzotti P, Phillips AN, Lepri AC, Rezza G. Coinfection of hepatitis C virus with human<br />
immunodeficiency virus and progression to AIDS. Italian Seroconversion Study. J Infect Dis. 1995<br />
Dec;172(6):1503-8.<br />
109. Haydon GH, F<strong>le</strong>gg PJ, Blair CS, Brett<strong>le</strong> RP, Burns SM, Hayes PC. The impact of chronic hepatitis C virus<br />
infection on HIV disease and progression in intravenous drug users. Eur J Gastroenterol Hepatol. 1998<br />
Jun;10(6):485-9.<br />
110. Dorrucci M, Valdarchi C, Suligoi B, Zaccarelli M, Sinicco A, Giuliani M, et al. The effect of hepatitis C on<br />
progression to AIDS before and after highly active antiretroviral therapy. Aids. 2004 Nov 19;18(17):2313-8.<br />
111. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, et al. Clinical progression, survival, and<br />
immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the<br />
Swiss HIV Cohort Study. Lancet. 2000 Nov 25;356(9244):1800-5.<br />
112. Piroth L, Grappin M, Cuzin L, Mouton Y, Bouchard O, Raffi F, et al. Hepatitis C virus co-infection is a<br />
negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients. J Viral<br />
Hepat. 2000 Jul;7(4):302-8.<br />
113. Daar ES, Lynn H, Donfield S, Gomperts E, O'Brien SJ, Hilgartner MW, et al. Hepatitis C virus load is<br />
associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis. 2001<br />
Feb 15;183(4):589-95.<br />
114. De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, et al. Coinfection with hepatitis viruses<br />
and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med.<br />
2002 Oct 14;162(18):2125-32.<br />
115. Yoo TW, Donfield S, Lail A, Lynn HS, Daar ES. Effect of hepatitis C virus (HCV) genotype on HCV and<br />
HIV-1 disease. J Infect Dis. 2005 Jan 1;191(1):4-10.<br />
116. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV<br />
disease. Jama. 2002 Jul 10;288(2):199-206.<br />
117. Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ. HIV and hepatitis C coinfection within the<br />
CAESAR study. HIV Med. 2004 May;5(3):174-9.<br />
181
Change language